The implications of TMSB4X in TIM3 hypermethylation and CD8+ T cell exhaustion in diffuse large B-cell lymphoma
Yiming Yang, Zujun Qin, Xin Liu, Huimin Yang, Xiaolin Wang, Chao Mai, Shunhai Jian, Qiqi Zhu · 2026
Read The implications of TMSB4X in TIM3 hypermethylation and CD8+ T cell exhaustion in diffuse large B-cell lymphoma by Yiming Yang, Zujun Qin, Xin Liu, Huimin Yang, Xiaolin Wang, Chao Mai, Shunhai Jian, Qiqi Zhu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13421516.txt.
Description
Yiming Yang and co-authors study a 2026 question in a fast-growing lymph cancer: why do the immune cells that should attack the tumor wear out? In diffuse large B-cell lymphoma, a checkpoint protein called TIM3 speeds the exhaustion of killer T cells. How TIM3 itself is switched on by chemical marks on DNA was unclear.
The team used single-cell gene data and staining to locate killer T cells and measure TIM3. They checked DNA marks on key checkpoint genes across groups with high and low TIM3. By joining mutation data, DNA marks, and gene activity from single cells and whole tumors, they found a hub gene, TMSB4X, tied to TIM3 control. They then weighed what that gene means for immune activity, the tumor's surroundings, patient outlook, and response to checkpoint drugs.
Catalog record
| CREATOR | Yiming Yang, Zujun Qin, Xin Liu, Huimin Yang, Xiaolin Wang, Chao Mai, Shunhai Jian, Qiqi Zhu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |